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hylogenetic analysis clusters caspase-12 with the in-
flammatory caspases 1 and 11. We analyzed the expres-
sion of caspase-12 in mouse embryos, adult organs,
and different cell types and tested the effect of interferons
(IFNs) and other proinflammatory stimuli. Constitutive expres-
sion of the caspase-12 protein was restricted to certain cell
types, such as epithelial cells, primary fibroblasts, and L929
fibrosarcoma cells. In fibroblasts and B16/B16 melanoma
cells, caspase-12 expression is stimulated by IFN-
 

 
 but not
by IFN-
 

 
 or -
 

 
. The effect is increased further when IFN-
 

 
is combined with TNF, lipopolysaccharide (LPS), or dsRNA.
P
 
These stimuli also induce caspase-1 and -11 but inhibit the
expression of caspase-3 and -9. In contrast to caspase-1
and -11, no caspase-12 protein was detected in macro-
phages in any of these treatments. Transient overexpression
of full-length caspase-12 leads to proteolytic processing of
the enzyme and apoptosis. Similar processing occurs in
TNF-, LPS-, Fas ligand–, and thapsigargin (Tg)-induced
apoptosis. However, B16/B16 melanoma cells die when
treated with the ER stress–inducing agent Tg whether they
express caspase-12 or not.
 
Introduction
 
Caspases are a family of cysteinyl aspartate proteinases central
in mediating cellular signals in apoptosis and inflammation
(Lamkanfi et al., 2003). The enzymes are produced as zy-
mogens consisting of a NH
 
2
 
-terminal prodomain of variable
length followed by a large and a small catalytic subunit. The
large prodomains of certain members of this protein family,
referred to as initiator caspases (e.g., caspase-8, -9, and -10),
contain interaction motifs consisting of six or seven antiparallel
amphipathic 
 

 
 helices. These prodomains were shown to allow
the recruitment and proximity-induced activation of the
enzymes in protein complexes (Stennicke and Salvesen,
2000). Caspases are usually activated by proteolysis that
leads to conformational changes of their catalytic parts
(Riedl et al., 2001). The mature caspase is a heterotetramer
consisting of two large and two small catalytic subunits
aligned in a head-to-tail configuration and contains an active
site in each of the opposite ends. Caspases typically signal
through proteolytic cascades in which initiator caspases
cleave and activate executioner caspases that lack a large pro-
domain (Slee et al., 1999; Van de Craen et al., 1999; Chang
and Yang, 2000). The final outcome of these cascades is the
specific proteolysis of a wide variety of substrates, leading either
 
to the loss of a life-saving function or the activation of
a proapoptotic or proinflammatory function (Chang and
Yang, 2000; Lamkanfi et al., 2003).
So far, 11 human and 10 murine caspases were identified
(Chang and Yang, 2000; Lamkanfi et al., 2002). Phylogenetic
analysis reveals that caspases segregate into three major
groups with different functions and substrate specificities.
The three groups are often referred to as inflammatory caspases,
apoptotic executioner caspases, and apoptotic initiator caspases
(Lamkanfi et al., 2002). Caspase-12 segregates with the inflam-
matory caspases including caspase-1, -4, -5, and -11 (Chang
and Yang, 2000; Lamkanfi et al., 2002). The amino acid
sequence identity of murine caspase-12 to the other members
of this group is as follows: murine caspase-1 (42%), human
caspase-1 (40%), murine caspase-11 (41%), human caspase-4
(48%), and caspase-5 (45%). These caspases seem to be
involved more in the maturation and secretion of proin-
 
flammatory cytokines such as interleukin (IL)-1
 

 
 and IL-18
than in the induction of death receptor–mediated apoptosis
(Martinon et al., 2002). All of the caspases included in the
group have a large prodomain containing a typical caspase
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recruitment domain (CARD). The genes encoding the mu-
rine members of the group are located on chromosome 9 in
the following order: caspase-1, caspase-11, and caspase-12.
The genes encoding their human counterparts reside on
chromosome 11q22, a region with synteny to murine chro-
mosome 9, and are arranged as follows from telomere to cen-
tromere: caspase-1, caspase-5, caspase-4, and finally a gene
encoding a pseudo caspase-12 (Fischer et al., 2002). The
predicted product of the latter gene is reported to be a cas-
pase-12–like protein with a premature stop and several point
mutations preventing the translated protein from having any
caspase-like enzymatic activity (Fischer et al., 2002). Studies
in caspase-12–deficient mice suggested that the protein plays
a major role in ER stress–induced apoptosis and in the devel-
opment of Alzheimer’s disease (Nakagawa et al., 2000).
Since then, several other reports have linked processing of
caspase-12 to ER stress–induced apoptosis (Rao et al., 2001,
2002; Diaz-Horta et al., 2002; Morishima et al., 2002). In
addition, caspase-12 seems to be involved in apoptosis in-
duced by viral infection (Bitko and Barik, 2001; Jordan et
al., 2002) or by serum starvation (Kilic et al., 2002).
Several reports have shown that the expression of certain
caspases is induced during inflammation. Treatment with
interferon (IFN)-
 

 
 increases the expression of caspase-8 in
many types of cells, thus sensitizing the cells to death do-
main receptor–mediated apoptosis (Dai and Krantz, 1999;
Ruiz-Ruiz et al., 2000; Fulda and Debatin, 2002). Both
IFN-
 

 
 and lipopolysaccharide (LPS) induce the expression
of human caspase-1, human caspase-5, and murine caspase-
11 but not of human caspase-4 (Tamura et al., 1996; Dai
and Krantz, 1999; Lin et al., 2000; Hur et al., 2001; Schauv-
liege et al., 2002). Although phylogenetic analysis suggests
that caspase-12 resembles other inflammatory caspases, it is
still unclear whether the regulation and processing of this
caspase is modulated in inflammation. Therefore, we ana-
lyzed the constitutive expression pattern of caspase-1, -11,
and -12 in mouse organs and during embryonic develop-
ment. We also tested the effect of IFNs and other proinflam-
matory stimuli on the expression of caspase-12 in several cell
lines both at the mRNA and protein levels. We compared
these effects with those observed with other caspases. In ad-
dition we tested the effect of TNF-, Fas ligand (FasL)–,
LPS-, and thapsigargin (Tg)-induced apoptosis on the pro-
cessing state of caspase-12.
 
Results
 
Analysis of the expression of caspase-12 during mouse 
embryonic development and in mouse organs 
and cell lines
 
A previous analysis of the expression pattern of caspase-12
in newborn mouse organs demonstrated that the enzyme is
found in many tissues and suggested that the protein is
widely expressed in a variety of cells (Nakagawa and Yuan,
2000). However, the Northern blot analysis presented in
our previous report demonstrated that the mRNA of cas-
pase-12 is mainly expressed in the lungs and skeletal muscle
(Van de Craen et al., 1997). In an attempt to resolve this ap-
parent discrepancy, we analyzed the expression pattern of
caspase-12 by RT-PCR during embryonic development and
in different adult mouse organs and by Western blotting in
different cell lines (Figs. 1 and 2). As caspase-12 is most sim-
ilar to caspase-1 and -11, we compared the constitutive ex-
pression pattern of these three caspases. The mRNAs of the
three proteins were highly expressed at day 7 of embryonic
development. All three caspases showed a drop in expression
at day 11, but whereas the mRNA of caspase-1 disappeared
by day 17, the expression levels of caspase-11 and -12
mRNAs increased gradually and reached the initial levels
again by that day (Fig. 1 A). The highest level of caspase-12
mRNA expression in adult mouse organs was observed in
lymph node, lung, and spleen (Fig. 1 B), confirming our
previous results (Van de Craen et al., 1997). The lowest cas-
pase-12 mRNA expression levels were detected in brain,
bone marrow, eye, and liver (Fig. 1 B). Interestingly, a dou-
ble band appeared, for example, in the testis, suggesting the
existence of a splice variant. Indeed, splice variants of mu-
rine caspase-12 and human pseudo caspase-12 were re-
ported before (Van de Craen et al., 1997; Fischer et al.,
Figure 1. Differential gene expression patterns of the mouse 
inflammatory caspase subfamily. Single-stranded cDNAs from 
multiple mouse tissues (panel I and II) were amplified by PCR using 
primers specific for caspase-1, -11, or -12. PCR for glyceraldehyde-3-
phosphate dehydrogenase (G3DPH) was performed to ensure that 
an equal quality and quantity of cDNA was used. Negative () and 
positive () PCR controls (CTRL) lacking or containing the specific 
cDNAs, respectively. (A) Expression of caspase-1, -11, and -12 
mRNA during mouse embryonic development. (B) Expression of 
caspase-1, -11, and -12 mRNA in different mouse organs.
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2002). Caspase-11 mRNA was observed in all analyzed or-
gans, though the expression levels in the lung, spleen,
uterus, and smooth muscle were clearly the highest (Fig. 1
B). Caspase-1 mRNA expression was detected in all of the
organs, with the lowest level in the liver and the kidney and
the highest in the spleen.
Using Western blot analysis, we checked the expression of
caspase-1, -11, and -12 at the protein level in lysates of sev-
eral organs from 5-wk-old mice (Fig. 2 A). The expression
pattern of caspase-1 at the protein level corresponded with
the RT-PCR results in Fig. 1 B. However, for caspase-12
and caspase-11, this correlation between protein and mRNA
expression levels was not obvious (Fig. 2). Expression of cas-
pase-12 protein was highest in skeletal muscle, heart, brain,
testis, and eye (Fig. 2 A). However, no, or hardly any, cas-
pase-12 protein was detected in the other organs tested. Al-
though high caspase-12 mRNA expression levels were de-
tected in the lymph node and the spleen, only very low
amounts of the protein could be detected in any of the he-
matopoietic organs tested. Caspase-11 expression was pre-
dominant in skeletal muscle followed by the heart and the
brain (Fig. 2 A).
Next, we analyzed, by Western blotting, extracts from
seven murine cell lines representing different cell types (B
cell hybridoma, T cells, preB cells, fibrosarcoma, melanoma,
and promyelocytes). A control lysate of HEK293T cells
transiently transfected with a plasmid leading to overexpres-
sion of caspase-12 revealed the 49-kD band expected for
full-length pro–caspase-12 and two additional bands run-
ning at 38- and 28-kD, respectively (Fig. 2 B). Caspase-12
protein was detected only in cells derived from the murine
fibrosarcoma cell line L929 (Fig. 2 B). In agreement with
the apparent absence of caspase-12 in lymphoid organs, no
caspase-12 protein was detected in cell lines of hematopoi-
etic origin. The strongest expression was detected in L929r2,
the cells from which the cDNA of caspase-12 was originally
cloned (Van de Craen et al., 1997). Analysis of 13.5-d-post-
coitum mouse embryos by immunohistochemistry revealed
that the most positively stained organ is the heart (Fig. 3, A
and B). In several other organs, including the lung and the
nose, the expression of the protein was confined to certain
cell types or layers, such as epithelium of the trachea and the
nose trail (Fig. 3, C and D). These results suggest that the
constitutive expression of caspase-12 is probably restricted to
certain cell types.
 
IFN-
 

 
 induces the expression of caspase-12 in mouse 
fibrosarcoma and melanoma cells: synergy with other 
proinflammatory stimuli
 
Several reports have demonstrated that the expression of
caspase-1 and -11 can be induced by proinflammatory stim-
uli such as IFN-
 

 
, TNF, or LPS (Lin et al., 2000; Schauv-
liege et al., 2002). The L929r2 murine fibrosarcoma and
B16/B16 murine melanoma cells respond to TNF only
when cotreated with IFN-
 

 
 (Mareel et al., 1988; Vanhaese-
broeck et al., 1991). Therefore, we compared the effect of
IFN-
 

 
 with and without TNF on the expression levels of
caspase-1, -11, and -12 in these two cell lines. Northern
blot analysis demonstrated that the expression of caspase-12
mRNA is further enhanced in L929r2 and induced in Bl6/
B16 cells by IFN-
 

 
 (Fig. 4). Synergism between TNF and
IFN-
 

 
 was observed with caspase-12 mRNA in B16/B16
cells and with caspase-11 mRNA in both L929r2 and B16/
B16 cells. Such an effect was not observed for caspase-1 and
-12 in L929r2 cells. Treatment of L929r2 cells for 24 h
with IFN-
 

 
 and TNF leads to cell death, about half of the
cells are propidium iodide positive at 24 h, whereas B16/
B16 cells still survive at that time point. This may explain
the apparent difference observed in the response of these
cell lines. An increase in caspase-1 mRNA was observed
only in L929r2 treated with IFN-
 

 
, whereas no caspase-1
mRNA expression was observed in B16/B16 cells in any of
the treatments.
Using Western blot analysis, we determined if the induc-
tion of caspase-12 mRNA expression in B16/B16 cells was
also reflected at the protein level and compared the effect
with that observed with other caspases (Fig. 5). Treatment
with IFN-
 

 
 increased the expression of caspase-1, -11, and
-12. When the treatment with IFN-
 

 
 was combined with
Figure 2. Western blot analysis of the expression of caspase-12 
protein in lysates of different mouse organs and cell lines. 
(A) Expression of caspase-1, -11, and -12 in adult mouse organs 
using anti–caspase-12 antiserum (Ab-1). *, antiserum G149 failed 
to detect caspase-12 expression in the brain (not depicted). 
(B) Analysis of the expression of caspase-12 protein in mouse cell 
lines representing different cell lineages. The cell lines used were 
7TD1 (mouse/rat B cell hybridoma), D10(N1) T cell lymphoma, 
FDCP1 (promyelocytoma), L929r2 and L929sA (fibrosarcoma), 
B16/B16 (melanoma), CTLrIL-2 (cytotoxic T cells), and WEHI-3 
(myelomonocytoma). Lysates of HEK293T cells transfected () or 
not () with a cDNA encoding for the corresponding caspase were 
used as positive and negative controls (CTRL), respectively. Arrows 
indicate bands corresponding to full-length (49 kD) or processed 
(38 and 28 kD) caspase-12.
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either TNF or LPS, the effect on the expression of caspase-1,
-11, and -12 was intensified (Fig. 5; Fig. 6 A). In contrast to
the caspases mentioned above, IFN-
 

 
 treatment led to a de-
crease in the expression levels of caspase-3 and -9. The dis-
appearance of the full-length form of these caspases (Fig. 5)
in B16/B16 cells was not due to proteolytic processing be-
cause no proteolytic fragments of caspase-3 and -9 were de-
tected. The antisera used reveal specific proteolytic process-
ing of caspase-3 and -9 during apoptosis (Fig. 8). As
expected, IFN-
 

 
 also increased the expression of the IFN-
inducible dsRNA-activated protein kinase (PKR), which we
used as a positive control (Baier et al., 1993). No effect was
observed on the level of 
 

 
-actin used as internal negative
control. Treatment with either TNF or LPS alone did not
affect the expression levels of any of the proteins. We ob-
served a similar effect of IFN-
 

 
 with and without TNF or
LPS on caspase-12 expression in another murine melanoma
cell line (PG19; unpublished data). These results suggest
that the activation of the gene coding for caspase-12 is
tightly regulated. Interestingly, the distinct effects on the
expression of the different caspases intensified in time, sug-
gesting that the expression of caspase-1, -11, and -12 was
induced, whereas that of the proapoptotic caspases 3 and 9
was suppressed (Fig. 5).
 
The expression of caspase-12 is not induced by 
type I IFNs
 
Next, we tested whether the effect on caspase-12 expression
is specific for IFN-
 

 
 or whether it also occurs with IFN-
 

 
 or
-
 

 
. Both IFN-
 

 
 and IFN-
 

 
 failed to induce the expression
of caspase-12. In contrast with the results obtained with
IFN-
 

 
, only a very faint caspase-12 signal could be detected
in Western blots of lysates of B16/B16 cells treated with the
combinations of type I IFNs with either TNF or LPS (Fig. 6
A). However, in cells treated with any one of the IFNs, the
expression level of caspase-3 was reduced (Fig. 6 A), con-
firming the results presented in Fig. 5. All three IFNs in-
duced the expression of PKR, demonstrating that the failure
of type I IFNs to induce the expression of caspase-12 did not
result from an incapacity of the cells to respond to these cy-
Figure 3. Immunohistochemical 
analysis of the expression of caspase-12 
in the mouse embryo. Caspase-12 
expression was detected in sections using 
either anti–caspase-12 rabbit antiserum 
Ab-1 or Ab-2. Results obtained with 
both antisera are similar (not depicted). 
Only those obtained with Ab-2 are 
presented. Negative controls of adjacent 
sections were stained by the anti–cas-
pase-12 antisera depleted with 
recombinant caspase-12. Sections stained 
by secondary antibody alone were 
completely negative (not depicted). 
(A) Sections of a 13.5-d-postcoitum 
embryo. Note the strong staining of heart, 
lung, and nose. White box shows the 
embryo at its relative real size (6 mm). 
(B) A close-up of the heart (1) in A. 
(C) A close-up of the lung (2) in A. Note 
the positive staining of the epithelial layer 
of the trachea. (D) A close-up of the nose 
(3) in A. Note the positive staining of the 
epithelium in the entrance of the nose. 
Bars: (A) 455 m; (B) 80 m; (C) 30 m; 
(D) 45 m.
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tokines. IFNs are known inducers of antiviral response. Be-
cause caspase-12 was implicated in the response to a viral in-
fection (Bitko and Barik, 2001; Jordan et al., 2002), we
wondered if dsRNA, a typical virus by-product, would fur-
ther modulate caspase-12 expression in the presence of IFN.
Interestingly, IFN-
 

 
, but not IFN-
 

 
, which is the antiviral
IFN per se, increased the expression of caspase-12 in synergy
with dsRNA (Fig. 6 B).
Macrophages play a major role in the response to both vi-
ral and bacterial infection and thus present a cellular model
that is highly relevant for inflammation (Stoy, 2001). More-
over, macrophages express caspase-1 and -11 and secrete ac-
tivated IL-1
 

 
 in response to infection and proinflammatory
stimuli (Lin et al., 2000; Schauvliege et al., 2002). There-
fore, we determined the effects of the three IFNs alone and
of IFN-
 

 
 in combination with LPS, TNF, or dsRNA on the
protein expression levels of caspase-1, -11, and -12 in the
Mf4/4 murine macrophage cell line. IFN-
 

 
, and to a lesser
extent also LPS and IFN-
 

 
, clearly induced the expression of
caspase-11. The expression of caspase-1 remained high and
stable (Fig. 7 A). However, no caspase-12–specific bands
were detected in Mf4/4 cells in any of the tested conditions
(Fig. 7 A). Similar results were obtained with J774 and
pU518, two other murine macrophage cell lines (unpub-
lished data) and primary peritoneal macrophages (Fig. 7 B).
The nonspecific bands detected in Fig. 7 A appeared after a
long exposure of the blot to the film. Similar bands were de-
tected by the G149 antiserum in HEK293T cells that do not
express murine caspase-12. Moreover, these bands were not
detected using two other distinct anti–caspase-12 antisera
(unpublished data).
Untreated primary fibroblasts, like the L929 fibrosarcoma
cells, constitutively expressed caspase-12 (Fig. 7 B). Treat-
ment of primary fibroblasts with IFN-
 

 
 strongly enhanced
the expression of the protein, and addition of either LPS or
TNF even intensified the effect further (Fig. 7 B). These re-
sults demonstrate that the expression of caspase-12, like that
of the proinflammatory caspases 1 and 11, can be induced in
cells exposed to IFN-
 

 
. However, the response might be re-
stricted to certain cell types, for example fibroblasts and me-
lanocytes, because macrophages that constitutively express
caspase-1 and can be induced to produce caspase-11 appar-
ently fail to express caspase-12.
 
Caspase-12 is processed in apoptotic cell death 
induced by FasL, TNF, or LPS
 
Transient overexpression of full-length wild-type caspase-12,
but not of its inactive C298A mutant, in HEK293T cells led
to processing of the protein and to apoptosis (Fig. 2 B; Fig.
8 A; Fig. 9 B). Processing of caspase-12 in these conditions
resulted in fragments of 
 

 
38 and 28 kD. These results sug-
gest that a link exists between the processing of caspase-12
and the induction of an apoptotic cell death. In rapid apop-
tosis occurring in L929sAhFas cells treated with FasL, cas-
pase-12 was fully processed, and only the 28-kD fragment
Figure 4. Effect of IFN- and TNF on the expression of the mRNAs 
of the mouse inflammatory caspase subfamily in L929r2 fibrosarcoma 
and B16/B16 melanoma cells. Cells were treated or not with IFN- 
(1,000 U/ml) or TNF (5,000 U/ml) alone or in combination. The next 
day, mRNA was extracted and analyzed by Northern blotting using 
specific probes. The size of the hybridizing bands is indicated in kb. 
UV imaging of ethidium bromide intercalated in the 18S and 28S 
rRNAs was used to monitor loading of the gels (bottom).
Figure 5. Analysis of the expression of caspase-12 and other 
caspases at the protein level in B16/B16 cells treated with IFN-, 
TNF, and LPS. Western blot analysis of lysates of B16/B16 cells 
treated for 9 or 24 h with IFN- (1,000 U/ml), TNF (5,000 U/ml), 
or LPS (1 g/ml) alone or in combinations, using antisera specific 
for the indicated murine caspases. Blots were revealed also with 
an anti–-actin antibody to verify that equal amounts of protein 
were loaded. The IFN-inducible kinase PKR was used as a positive 
control, demonstrating responsiveness to IFN. CTRL indicates 
untreated controls.
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was observed (Fig. 8 B). The processing of caspase-12 in the
latter cells coincided with the activation of caspase-3, -7, and
-9 (Fig. 8 B). Treatment of B16/B16 cells with TNF alone
had no effect on their growth, whereas treatment with either
IFN-
 

 
 or LPS alone led to a decrease in the proliferation rate
without any apparent signs of cell death (Fig. 9 A). How-
ever, light microscopy analysis demonstrated that cells
treated with a combination of IFN-
 

 
 with LPS or TNF
rounded up and started floating and eventually died and dis-
integrated (Fig. 9 A; unpublished data). We tested whether
caspase-12 is also processed in this kind of cell death. As seen
before (Figs. 5 and 6), the protein was highly expressed in all
the conditions that included IFN-
 

 
. However, processing of
caspase-12 was detected only when the cells were treated
with the combination of IFN-
 

 
 with either LPS or TNF
(Fig. 9 B). These results show that caspase-12 is processed in
different proapoptotic conditions, including those induced
by TNF, LPS, and FasL, and suggest that it may actively
contribute to the cell death process.
 
Caspase-12 is dispensable for Tg-induced 
ER stress–mediated apoptosis
 
Several reports have proposed that caspase-12 plays a major
role in ER stress–induced apoptosis (Rao et al., 2001, 2002;
Diaz-Horta et al., 2002; Morishima et al., 2002). As B16/
B16 cells express caspase-12 only when they are treated with
IFN-
 

 
, we used these cells to test if caspase-12 is required for
ER stress–mediated apoptosis induced by Tg. B16/B16 cells
died in response to Tg in the presence or absence IFN-
 

 
(Fig. 10 A). Light microscopy analysis revealed that in both
cases, cells dying in response to Tg were blebbing and had
the typical apoptotic morphology similar to that seen with
HEK293T overexpressing caspase-12 (Fig. 8 A). Although
IFN-
 

 
 treatment clearly sensitized the cells to TNF-induced
cytotoxicity (Fig. 10 A), the effect of IFN-
 

 
 on Tg-induced
cell death was minor. To analyze the expression and process-
ing pattern of caspase-12 in response to Tg and compare it
with that observed in IFN-
 

 
 
 

 
 TNF–treated cells, we used
two different anti–caspase-12 antisera. The first antiserum,
Ab-2, was raised against a peptide spanning residues 2–17 in
the amino acid sequence of caspase-12 and thus recognized
fragments containing the prodomain of the protein, and the
second antiserum, G149, was raised against the catalytic
parts of the enzyme (Fig. 10 B). Both antisera detected the
Figure 6. Comparison of the effect of type I and type II IFNs on 
the expression of caspase-12 and -3 by B16/B16 cells. (A) Western 
blot analysis of cells treated for 24 h with IFN-, -, or - (1,000 IU/ml) 
in the presence or absence of TNF (5,000 IU/ml) or LPS (1 g/ml). 
(B) Western blot analysis of cells treated for 24 h with IFN- or - 
(1,000 IU/ml) in the presence or absence of dsRNA (100 g/ml). 
The IFN-inducible kinase PKR was used as a positive control for 
responsiveness to the different IFNs. An anti–-actin antibody was 
used to verify that equal amounts of protein were loaded.
Figure 7. Analysis of the expression of caspase-12 in macrophages 
and primary fibroblasts. (A) Western blot analysis of Mf4/4 
macrophages treated for 24 h with IFN-, - or, - (1,000 IU/ml) 
in the presence or absence of TNF (5,000 IU/ml), LPS (1 g/ml), 
or dsRNA (50 g/ml). C-12 indicates a lysate of HEK293T cells 
overexpressing caspase-12, used as a positive control. *, nonspecific 
bands. (B) Western blot analysis of primary fibroblasts and peritoneal 
macrophages treated for 24 h with IFN- (1,000 IU/ml) in the presence 
or absence of TNF (5,000 IU/ml) or LPS (1 g/ml). B16/B16 cells 
treated or not with IFN- (1,000 IU/ml) were used as a positive control. 
An anti–-actin antibody was used to verify that equal amounts of 
protein were loaded.
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full-length 49-kD protein in cells treated with IFN-
 

 
 but
failed to detect the expression of caspase-12 in cells treated
with Tg alone (Fig. 10 C). The level of caspase-12 ex-
pression seen in cells cotreated with IFN-
 

 
 and Tg was
lower than in cells treated with IFN-
 

 
 in the absence of Tg.
This may be explained by a decrease in translation due to
Tg treatment (Wong et al., 1993). Caspase-12 processing
clearly occurred in cells treated with the combination of
IFN-
 

 
 and TNF or Tg (Fig. 10 C). Ab-2 detected the 38-
kD fragment of caspase-12 in cells treated with IFN-
 

 
 
 

 
TNF but failed to detect this fragment in cells treated with
IFN-
 

 
  Tg, whereas G149 detected the 28-kD fragment
in both types of treatments (Fig. 10 C). These results suggest
that the 38-kD fragment lacks only the COOH-terminal
small catalytic subunit (SCSU), and that the 28-kD frag-
ment is missing both the SCSU and the prodomain and,
thus, probably corresponds to the mature large catalytic sub-
unit (LCSU) (Fig. 10, B and C). Taken together, these re-
sults demonstrate that caspase-12 is not required for Tg-
induced cell death, although treatment with Tg can induce
the proteolytic cleavage of the protease.
Discussion
In the current report, we investigated the expression of cas-
pase-12 during mouse embryonic development and in adult
mouse organs. We compared the regulation of the expres-
sion of caspase-12 by proinflammatory stimuli with that of
other caspases. Although the mRNAs of caspase-1, -11, and
-12 are expressed in most of the organs tested, the level of
expression varies substantially. For example, all three cas-
pases were highly expressed in the spleen, whereas only cas-
pase-11 and -12 were highly expressed in the lungs. Similar
results were obtained before for murine caspase-1, -11, and
-12 using Northern blots (Van de Craen et al., 1997) and
for human caspase-1, -4, and -5 by RT-PCR (Lin et al.,
2000). By analyzing a battery of mouse cell lines of various
lineages, we show that the expression of caspase-12 at the
protein level is more restricted than expected. Indeed, the
only cells we observed to constitutively express the protein
are primary fibroblasts and L929 fibrosarcoma cells. This
suggests that although caspase-12 can be detected in most
organs, only some of the cells in these organs are expressing
the protease. This suggestion was clearly supported by the
immunohistochemical analysis that demonstrated that in
Figure 8. Processing of caspase-12 in apoptosis induced by 
overexpression of the full-length protein in HEK293T cells and in 
L929sAhFas cells treated with FasL. (A) HEK293T cells were 
transiently cotransfected with a plasmid encoding for a nuclear 
localization signal containing GFP and a plasmid encoding for 
either the wild type (C-12 wt) or an inactive caspase-12 mutant 
(C-12 C298A). Fluorescent microscopy photographs and Western 
blot analysis demonstrate that although both of the caspase-12 
variants are expressed in equal levels, only the wild-type protein 
is processed and leads to apoptotic cell death. Bar, 5 m. Arrows 
indicate fragments corresponding to caspase-12 and their size in 
kD. (B) L929sAhFas cells were treated with recombinant soluble 
FasL for the indicated time. Cytotoxicity was measured by trypan 
blue (TB) exclusion. CTRL indicates untreated controls. Processing 
of caspase-3, -7, -9, and -12 after a 2-h treatment with FasL was 
determined by Western blotting. Arrows indicate the proteolytically 
processed caspase fragments and their size in kD.
Figure 9. Caspase-12 is processed in B16/B16 cells dying from 
the combination of IFN- with either LPS or TNF. (A) Analysis of the 
cytotoxic potential of IFN-, TNF, or LPS. Cells were treated with 
IFN- (1,000 U/ml), TNF (5,000 U/ml), or LPS (1 g/ml) alone or in 
combinations. Cell viability was measured at the indicated time using 
MTT. CTRL indicates untreated controls. Error bars, standard deviation 
of six replicates of a representative experiment. (B) Western blot 
analysis of cells treated for 48 h with IFN- (1,000 U/ml), TNF 
(5,000 U/ml), or LPS (1 g/ml) alone or in combinations. C-12 
indicates lysate of HEK293T cells overexpressing caspase-12, used 
as a positive control. Arrows indicate bands corresponding to 
the 49-kD full-length pro–caspase-12 and to the 38- and 28-kD 
fragments of the processed caspase. *, nonspecific bands.
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most positive organs, only certain cell layers, such as epithe-
lium of the trachea in the lung and the nose trail, express
the caspase.
Protein sequence comparison shows that caspase-12 most
resembles caspase-1 and -11. Caspase-1 and its cytokine sub-
strates IL-1 and IL-18 play an important role in immune
and inflammatory responses to endotoxins and bacterial
infection such as Shigella flexneri and Escherichia coli
(Dinarello, 1998; Sansonetti et al., 2000; Joshi et al., 2002).
Mice deficient in caspase-1 are resistant to endotoxic shock
and are defective in LPS-induced secretion of IL-1, IL-1,
IL-18, and IFN- (Li et al., 1995; Fantuzzi et al., 1997,
1998; Burgess et al., 1998). Caspase-11–deficient mice
present a similar phenotype in addition to the lack of the
ability to respond to LPS by caspase-1 processing, a function
that apparently requires caspase-11 (Wang et al., 1998). In
humans, caspase-1 and IL-1 activation was shown to in-
volve the formation of a complex including caspase-1 and
caspase-5 (Martinon et al., 2002). Murine caspase-11 can
also form a complex with, and is required for the activation
of, caspase-1 (Wang et al., 1998) and therefore may have a
function similar to that of human caspase-5. The phylogenic
clustering of caspase-1, -4, -5, -11, and -12 suggests a role for
the latter caspase in inflammatory responses. As seen with
caspase-1 and -11, the expression of caspase-12 is stimulated
by IFN- in fibrosarcoma and melanoma cells. In contrast to
IFN- and -, which are produced by most cell types in re-
sponse to viruses or dsRNA, production of IFN- is re-
stricted to cells of the immune system (Katze et al., 2002).
These include natural killer (NK) cells, CD4 T helper 1
(TH1) cells, and CD8 cytotoxic T cells stimulated by IL-12
and IL-18 secreted from activated macrophage or dendritic
cells (Murphy and Reiner, 2002). IFN- and - are mainly
involved in the response to viral infection (Katze et al., 2002;
Taniguchi and Takaoka, 2002). Although IFN- has an an-
tiviral function, the cytokine acts mainly as an effector cyto-
kine required for cell-mediated immunity (Murphy and
Reiner, 2002; Gordon, 2003). Moreover, IFN- is a strong
activator of proinflammatory and microbicidal functions of
macrophages (Gordon, 2003). Remarkably, expression of
caspase-12 is induced exclusively by IFN- and not by IFN-
or -. Does this suggest that caspase-12 plays a role in anti-
bacterial or proinflammatory activities? The answer is far
from clear, as the cellular substrates of the protease are still
unknown. In contrast to caspase-1 and -11, caspase-12 is not
expressed in macrophages, a typical example of inflammatory
cells. Moreover, overexpression of caspase-12 in several cell
lines together with pro–IL-1 does not lead to secretion of
active IL-1 (Van de Craen et al., 1997; unpublished data),
excluding a direct role for the protease in IL-1 maturation.
In addition, although caspase-12–deficient mice were made
(Nakagawa et al., 2000), nothing has been published yet on
the response of these deficient mice to proinflammatory or
endotoxic stimuli or to bacterial infection.
Activation of caspase-1 or -11 due to exposure to LPS or
bacterial infection can also lead to apoptosis (Chen et al.,
1996; Hilbi et al., 1998; Kang et al., 2000, 2002; Hisahara
et al., 2001). Caspase-12 may exert a similar function. Our
results demonstrate that overexpression of caspase-12 in
HEK293T cells leads to processing of the enzyme and to
apoptosis. We observed similar processing of caspase-12 in
B16/B16 cells dying in response to IFN- combined with
either TNF or LPS and in L929sAhFas cells dying by Fas-
mediated apoptosis. Interestingly, in B16/B16 cells treated
with IFN-, expression of the typical apoptotic caspases 3
and 9 decreased, whereas that of caspases 1, 11, and 12 went
up. This down-regulation of the apoptotic caspases versus
the up-regulation of the inflammatory caspases may suggest
that IFN- prepares the cells for an alternative caspase cas-
cade, avoiding the intrinsic apoptotic pathway.
The inducible expression of caspase-12 in B16/B16 cells
allowed us to study the involvement of the protein in Tg-
Figure 10. Caspase-12 is dispensable for Tg-induced ER stress–
mediated apoptosis in B16/B16 cells. (A) Analysis of the cytotoxic 
effect of Tg (2 M) alone or in combination with IFN- (1,000 IU/ml) 
compared with TNF (5,000 IU/ml). Cell viability was measured at 
the indicated time using MTT. CTRL is untreated control. Error bars, 
standard deviation of six replicates of a representative experiment. 
(B) Schematic representation of pro–caspase-12 indicating the 
relative location of the peptides used to produce the anti–caspase-12 
antisera Ab-2 and G149. Ab-2 was raised against a peptide spanning 
amino acids 2–17 of caspase-12 and is specific for the NH2-terminal 
prodomain. G149 was raised against a recombinant protein spanning 
amino acids 116–419 of caspase-12 and recognizes the catalytic 
part of the protein. LCSU and SCSU indicate the large and the small 
catalytic subunits of the caspase, respectively. (C) Western blot 
analysis of cells treated for 72 h with IFN- (1,000 IU/ml), TNF 
(5,000 IU/ml), or Tg (2 M) alone or in combinations. C-12 indicates 
lysate of HEK293T cells overexpressing caspase-12, used as a positive 
control. Arrows indicate bands corresponding to the 49-kD full-length 
pro–caspase-12 and to the 38- and 28-kD fragments of the processed 
caspase. *, nonspecific bands.
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induced ER stress–mediated apoptosis. Our results clearly
show that the cells die in response to Tg whether caspase-12
is present or not. They also demonstrate that in cells express-
ing caspase-12, the enzyme is processed and probably acti-
vated in a variety of apoptotic conditions. In view of the re-
stricted expression pattern of caspase-12 to certain cell types
and the fact that its closest homologue encoded in the hu-
man genome is not a functional protease, we suggest that al-
though the protein may have a function in apoptotic cell
death, it is not likely to be the initiator of ER stress–medi-
ated apoptosis. Despite the absence of caspase-12 in stimu-
lated macrophages, the induction of the expression and pro-
cessing of the protease by proinflammatory stimuli in
fibroblasts may still suggest a role in the immune or inflam-
matory response in the mouse.
Materials and methods
Antibodies, cytokines, and reagents
Recombinant murine TNF (specific biological activity of 2.2  108 IU/ml)
was produced in E. coli and purified in our laboratory. Recombinant mu-
rine IFN- was from BioSource International. Recombinant murine IFN-
and IFN- were produced in E. coli and purified in our laboratory. Flag-
tagged human FasL was expressed in HEK293T cells and purified in house.
Poly(I)-poly(C) (synthetic dsRNA) was dissolved at 3.5 mg/ml in water (Am-
ersham Biosciences). LPS (Salmonella abortus equi) was from Sigma-
Aldrich. Anti–murine caspase-9 antibody was from New England Biolabs,
Inc. Rabbit polyclonal antiserum against recombinant murine caspase-1,
-3, -7, and -11 and caspase-12 (G149) were prepared at the Centre d’Econ-
omie Rurale (Laboratoire d’Hormonologie Animale). Purified anti–cas-
pase-12 antisera, Ab-1 and Ab-2, were from Oncogene Research Products.
The anti–caspase-12 antiserum used in all Western blot analyses, unless
otherwise indicated, is G149. Antiserum specific for mPKR was from Santa
Cruz Biotechnology, Inc., and antibody to -actin was from ICN Biomedi-
cals. Determination of protein concentration in cell lysates was performed
using a Bio-Rad Laboratories protein assay.
RT-PCR analysis
Mouse multiple tissue cDNA (MTCTM) panels I and II were from CLON-
TECH Laboratories, Inc. PCR was performed in a total volume of 50 l PCR
buffer containing 2 mM MgSO4, 0.4 mM deoxynucleoside triphosphates,
0.5 M each primer, 2.5 U of Pfx Platinum DNA polymerase (Invitrogen),
and 5 l of first strand cDNA of tissue or embryo cDNA. The PCR cycle
started at 94	C for 2 min, followed by a three-step cycling: denaturation at
94	C for 15 s, annealing at either 58	C or 62	C (depending on the primers
used) for 30 s, and extension at 72	C for 90 s. This was followed by a final
extension step at 72	C for 5 min. In each experiment, PCR for glyceralde-
hyde-3-phosphate dehydrogenase (G3DPH) was performed according to
the manufacturer’s instructions using primers provided by CLONTECH
Laboratories, Inc., to ensure that an equal quality and quantity of cDNA
was used. To avoid PCR products reaching saturation, 30 PCR cycles were
used for caspase-1, -11, and -12 and 22 cycles for G3DPH. The primers for
mouse caspase-12 were derived from the 5
 end of the full-length cDNA
and from the 3
 end of the predicted large catalytic subunit (Van de Craen
et al., 1997). The primers for caspase-1 and -11 were derived from the 5

and 3
 ends of the respective open reading frames.
Plasmids and transfection of HEK293T cells
The cloning of the cDNA encoding for full-length caspase-12 from a
cDNA library derived from L929r2 cells and its transfer to the pCAGGS eu-
karyotic expression vector were described previously (Van de Craen et al.,
1997). In pCAGGS-caspase-12 C298A, the codon for the catalytic cysteine
was substituted by that coding for alanine, leading to the expression of an
inactive form of the enzyme. pNLS-EGFP is a modified pEGFP-N1 plasmid
(CLONTECH Laboratories, Inc.) encoding GFP with a nuclear localization
signal. HEK293T cells were transiently cotransfected using calcium phos-
phate precipitation in six-well culture dishes with 50 ng of pNLS-EGFP and
600 ng of either pCAGGS-caspase-12 or pCAGGS-caspase-12 C298A. The
next day, cells were examined and photographed using a fluorescent mi-
croscope. Cells were harvested and lysed for Western blot analysis as de-
scribed below.
Preparation of protein extracts from mouse organs
Mouse organs were isolated, and samples from three to six mice were
pooled and frozen in liquid nitrogen. Tissues were thawed and homoge-
nized on ice with an RZR homogenizer (Heidolph-Instruments) in PBS-A
supplemented with 1 mM leupeptin, 1 mM aprotinin, 0.1 mM PMSF, and
1 mM oxidized glutathione. The homogenates were diluted in an equal
volume of caspase lysis buffer containing 0.05% Nonidet-P40, 220 mM
mannitol, 68 mM sucrose, 2 mM NaCl, 2.5 mM KH2PO4, 10 mM Hepes,
pH 7.4, 1 mM leupeptin, 1 mM aprotinin, 0.1 mM PMSF, and 1 mM oxi-
dized glutathione and incubated on ice for 10 min. Cell debris was re-
moved by centrifugation, protein concentrations were measured using a
Bio-Rad Laboratories protein assay, and 50 g from each sample was
taken for Western blot analysis.
Immunohistochemistry
BALB/c mouse embryos, aged 13.5 d postcoitum, were fixed in 4% para-
formaldehyde, embedded in paraffin, and sliced (4–6 m). Endogenous
peroxidase was blocked with peroxidase blocking reagent (DakoCytoma-
tion). Caspase-12 expression was detected in sections using either anti–
caspase-12 rabbit antiserum, Ab-1 or Ab-2. Binding of primary antibody
was revealed by 45 min incubation with a rat anti–rabbit antibody conju-
gated to peroxidase (DakoCytomation) followed by incubation with the
3,3
-diaminobenzidine chromogen (DakoCytomation). Negative controls
were stained by the secondary antibody alone or by the anti–caspase-12
rabbit antiserum depleted with a His6-tagged recombinant caspase-12 pro-
duced in E. coli and captured on Ni-NTA (QIAGEN). The specificity of the
depletion procedure was controlled by passing anti–caspase-12 antiserum
over a Ni-NTA column. Furthermore, the specificity of the antisera to cas-
pase-12 was verified by immunostaining of HEK293T transfected or not
with pCAGGS-caspase-12 C298A using a similar staining technique.
Northern blot analysis
B16/B16 or L929r2 cells were seeded at 1.2  103 cells per cm2. The next
day, cells were left untreated or treated with either IFN- (1,000 U/ml) or
TNF (5,000 U/ml) alone or in combination. Cells were harvested 20 h
later, and total RNA was extracted from 4  106 cells using RNAzol™
(WAK-Chemie Medical GmbH). After electrophoretic separation on a 1%
formaldehyde agarose gel, RNA was transferred to a Hybond-N mem-
brane and fixed by UV light. Membranes were incubated in prehybridiza-
tion solution (50 mM Tris-HCl, pH 7.4, 40% formamide, 4 SSC, 10
Denhardt’s solution, 0.1% Na4P2O7, 1% SDS, and 20 g/ml herring sperm
DNA) for 2 h at 42	C. DNA probes for caspase-1, -11, and -12 were la-
beled with [32P]dCTP using random primering (Boehringer) and incubated
overnight at 42	C with the prehybridized membrane. Filters were washed
with 2 SSC, 0.1% SDS at room temperature and then exposed to an X-ray
film at 80	C.
Cell culture and treatment
Murine Mf4/4 macrophages (Desmedt et al., 1998) and B16/B16 cells
were maintained in LPS-free RPMI 1640 medium (GIBCO BRL) supple-
mented with 10% FCS (GIBCO BRL), 0.03% L-Gln (Merck), 100 U/ml pen-
icillin, 100 g/ml streptomycin, and 50 M -mercaptoethanol at 37	C in
a humidified 5% CO2 atmosphere. Before analysis, cells were seeded at
3  105 cells/2 ml/well in six-well tissue culture plates (Falcon; Becton
Dickinson) in fresh growth medium. The next day, cells were left untreated
or were treated as indicated.
Mouse embryonic fibroblasts were isolated from BALB/c mouse embryos
by collagenase treatment and incubated in DMEM.NUT.MIX.F-12 medium
supplemented with GLUTAMAX-I, pyridoxine, and 15% FCS. For analysis,
cells were seeded at 3  105 cells/2 ml/well in six-well tissue culture plates
in fresh growth medium. The next day, cells were treated as indicated.
Peritoneal macrophages were obtained by washing the peritoneal cavity
of three adult C57/BL6 mice with PBS-A. May-Grünwald/Giemsa (Sigma-
Aldrich) staining performed after the removal of erythrocytes by a hypo-
tonic treatment demonstrated that 90% of the recovered cells had a
monocyte/macrophage-like morphology. The remaining cells were seeded
at 106 cells/1 ml/well in six-well tissue culture plates in LPS-free RPMI 1640
medium supplemented with 10% FCS, 0.03% L-Gln, 100 U/ml penicillin,
100 g/ml streptomycin, and 50 M -mercaptoethanol and allowed to ad-
here for 1.5 h. After the removal of suspension cells and refreshment of the
medium (2 ml/well), adherent cells were treated as indicated.
The human Fas-expressing L929sA cells (L929sAhFas) were described
previously (Vercammen et al., 1998). L929sAhFas cells were seeded in
9-cm plates at 3.106/plate. The next day, cells were treated with medium
or recombinant Flag-tagged FasL (1/500 dilution), and cell death was de-
termined by trypan blue staining in 2-h intervals. Cells were lysed 2 h after
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FasL treatment in 20 mM Hepes, pH 7.0, 0.1% CHAPS, 5 mM DTT, 1 mM
leupeptin, 1 mM aprotinin, and 0.1 mM PMSF. Cell debris was removed
by centrifugation, protein concentrations were measured, and 30 g from
each sample was taken for Western blot analysis.
Western blot analysis
With the exception of L929sAhFas, all cells were harvested, washed with
ice-cold PBS-A, and lysed on ice with caspase lysis buffer. Cell debris was
removed by centrifugation, and protein concentrations were measured.
From each sample, 10 g of HEK293T cell lysate, 50 g of melanoma cell
or macrophage cell lysate, or 30 g of primary fibroblast cell lysate was
taken for Western blot analysis. A lysate of HEK293T cells expressing the
wild-type protein was used as a positive control for caspase-12 expression.
Samples were boiled for 10 min in SDS-PAGE sample buffer, separated in
12.5 or 15% SDS-PAGE gels, as indicated, and transferred to nitrocellu-
lose. Blocking, antibody incubation steps, and washing of the membrane
were performed in PBS supplemented with 0.05% Tween-20 and 3%
skim milk. After the incubation with the primary antibody of choice and
washing, membranes were incubated with the appropriate horseradish
peroxidase–conjugated secondary antibodies to mouse and rabbit immu-
noglobulin (Amersham Biosciences). Proteins were visualized using a
chemiluminescence substrate (PerkinElmer), and blots were exposed to
film (Amersham Biosciences).
Cell survival assay
B16/B16 cells were seeded at 2  103 cells per well, respectively, in 96-
well plates. The next day, cells were left untreated or were treated with
IFN- (1,000 IU/ml), TNF (5,000 IU/ml), LPS (1 g/ml), or Tg (1 M) alone
or with combinations of IFN- with TNF, LPS, or Tg. Cell survival was as-
sessed at the indicated time using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT; Sigma-Aldrich) (Tada et al., 1986). The
percentage of cell death was calculated using the following equation:
100%  (1  (A595/655-treated cells  A595/655 medium)/(A595/655-untreated
cells  A595/655 medium).
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